Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control

Peter J Hotez, Lorenzo Savioli, Alan Fenwick, Peter J Hotez, Lorenzo Savioli, Alan Fenwick

Abstract

The neglected tropical diseases (NTDs) are highly endemic but patchily distributed among the 20 countries and almost 400 million people of the Middle East and North Africa (MENA) region, and disproportionately affect an estimated 65 million people living on less than US$2 per day. Egypt has the largest number of people living in poverty of any MENA nation, while Yemen has the highest prevalence of people living in poverty. These two nations stand out for having suffered the highest rates of many NTDs, including the soil-transmitted nematode infections, filarial infections, schistosomiasis, fascioliasis, leprosy, and trachoma, although they should be recognized for recent measures aimed at NTD control. Leishmaniasis, especially cutaneous leishmaniasis, is endemic in Syria, Iran, Iraq, Libya, Morocco, and elsewhere in the region. Both zoonotic (Leishmania major) and anthroponotic (Leishmania tropica) forms are endemic in MENA in rural arid regions and urban regions, respectively. Other endemic zoonotic NTDs include cystic echinococcosis, fascioliasis, and brucellosis. Dengue is endemic in Saudi Arabia, where Rift Valley fever and Alkhurma hemorrhagic fever have also emerged. Great strides have been made towards elimination of several endemic NTDs, including lymphatic filariasis in Egypt and Yemen; schistosomiasis in Iran, Morocco, and Oman; and trachoma in Morocco, Algeria, Iran, Libya, Oman, Saudi Arabia, Tunisia, and the United Arab Emirates. A particularly noteworthy achievement is the long battle waged against schistosomiasis in Egypt, where prevalence has been brought down by regular praziquantel treatment. Conflict and human and animal migrations are key social determinants in preventing the control or elimination of NTDs in the MENA, while local political will, strengthened international and intersectoral cooperative efforts for surveillance, mass drug administration, and vaccination are essential for elimination.

Figures

Figure 1. Map of the Middle East…
Figure 1. Map of the Middle East and North Africa region.

References

    1. World Health Organization. 2010. 172 Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases.
    1. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the “bottom billion” through neglected tropical disease control. Lancet. 2009;373:1570–1574.
    1. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Roses Periago M. The neglected tropical diseases of Latin America and the Caribbean: review of estimated disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis. 2008;2:e300. doi: .
    1. Hotez PJ. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis. 2008;2:e256. doi: .
    1. Hotez PJ. Neglected infections of poverty among the indigenous peoples of the Arctic. PLoS Negl Trop Dis. 2010;4:e606. doi: .
    1. Hotez PJ, Gurwith M. Europe's neglected infections of poverty. Int J Infect Dis. 2011;15:e611–e619.
    1. Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution and disease burden. PLoS Negl Trop Dis. 2009;3:e412. doi: .
    1. Hotez PJ, Ehrenberg J. Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific Region. Adv Parasitol. 2010;7C2:31–53.
    1. Lobo DP, Velayudhan R, Chatterjee P, Kohl H, Hotez PJ. The neglected tropical diseases of India and South Asia: review of their prevalence, distribution, and control or elimination. PLoS Negl Trop Dis. 2011;5:e1222. doi: .
    1. Hotez PJ, Alibek K. Central Asia's hidden burden of neglected tropical diseases. PLoS Negl Trop Dis. 2011;5:e1224. doi: .
    1. World Bank. Middle East and North Africa regional brief. 2011. Available: . Accessed 2011 Jun 25.
    1. Population Reference Bureau. DataFinder. n.d.. Available: . Accessed 2011 June 15.
    1. World Bank. Poverty. n.d.. Available: . Accessed 26 June 2011.
    1. World Bank. Poverty gap at $2 a day (PPP) (%). n.d.. Available: . Accessed 2011 June 26.
    1. The World Bank. Data: Middle East & North Africa. n.d.. Available: . Accessed 15 June 2011.
    1. Gwida M, Al Dahouk S, Melzer F, Rosler U, Neubauer H, et al. Brucellosis- regionally emerging zoonotic disease? Croat Med J. 2010;51:289–295.
    1. Weina PJ, Neafie RC, Wortmann G, Polheus M, Aronson NE. Old world leishmaniasis: an emerging infection among deployed US military and civilian workers. Clin Infect Dis. 2004;39:1674–1680.
    1. deSilva NR, Brooker S, Hotez PJ, Montresor A, Engels D, et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003;19:547–551.
    1. Brooker S, Hotez PJ, Bundy DA. The global atlas of helminth infection: mapping the way forward in neglected tropical diseases control. PLoS Negl Trop Dis. 2010;4:e779. doi: .
    1. El-Kholy SI, Abdel-Magied S, El-Ganayni GA. Some epidemiological studies on Ancylostoma duodenale infection. J Egypt Soc Parasitol. 1983;13:447–453.
    1. Sadaga GA, Kassem HH. Prevalence of intestinal parasites among primary schoolchildren in Derna District, Libya. J Egypt Soc Parasitol. 2007;37:205–214.
    1. Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283–295.
    1. Raja'a YA, Mubarak JS. Intestinal parasitosis and nutritional status in schoolchildren of Sahar district, Yemen. East Mediterr Health J. 2006;12(Suppl 2):S189–S194.
    1. Al-Haddad AM, Baswaid SH. Frequency of intestinal parasitic infection among children in Hadhramout governate (Yemen). J Egypt Soc Parasitol. 2010;40:479–488.
    1. Antonios SN, Eid MM, Khalifa EA, Othman AA. Seroprevalence study of Toxocara canis in selected Egyptian patients. J Egypt Soc Parasitol. 2008;38:313–318.
    1. El-Shazly AM, Mohammed RM, El-Beshbishi SN, Azab MS, El-Ghareeb AS, et al. Soil-parasites particularly Toxocara eggs in Egypt. J Egypt Soc Parasitol. 2009;39:151–162.
    1. El-Shazly AM, Abdel Baset SM, Kamal A, Mohammed KA, Sakrs TI, et al. Seroprevalence of human toxocariasis (visceral larva migrans). J Egypt Soc Parasitol. 2009;39:731–744.
    1. Zibaei M, Abdollahpour F, Birjandi M, Firoozeh F. Soil contamination with Toxocara spp. eggs in the public parks from three areas of Khorram Abad, Iran. Nepal Med Coll J. 2010;12:63–65.
    1. World Health Organization. Soil-transmitted helminthiasis. Weekly Epidemiol Rec. 2008;83:237–252.
    1. World Health Organization. Global Programme to Eliminate Lymphatic Filariasis. 2010. Progress Report 2000–2009 and Strategic Plan 2010–2020; Preventive Chemotherapy and Transmission Control (PCT), Department of Control of Neglected Tropical Diseases.
    1. Ramzy RMR, Goldman AS, Kamal HA. Defining the cost of the Egyptian lymphatic filariasis elimination programme. Filaria J. 2005;4:7.
    1. El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, et al. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg. 2007;77:1069–1073.
    1. World Health Organization. Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration. Wkly Epidemiol Rec. 2010;86:377–388.
    1. Helmy MM, Al Mathal IM. Human infection with Onchocerca volvulus in Asir District (Saudi Arabia). J Egypt Soc Parasitol. 2003;33:385–390.
    1. Scrimgeour EU, Mehta FR, Suleiman AJM. Infectious and tropical diseases in Oman: a review. Am J Trop Med Hyg. 1999;61:920–925.
    1. Fenwick A, Rollinson, Southgate V. Implementation of human schistosomiasis control: challenges and prospects. Adv Parasitol. 2006;61:567–622.
    1. Amarir F, El Mansouri B, Fellah H, Sebti F, Mohammed L, et al. National serologic survey of haematobium schisosomiasis in Morocco: evidence for elimination. Am J Trop Med Hyg. 2011;84:15–19.
    1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2008;6:411–425.
    1. Farley J. Bilharzia: a history of imperial tropical medicine. Cambridge studies in the history of medicine. Cambridge: Cambridge University Press; 1991. 299
    1. Salem S, Mitchell RE, El-Alim El-Dorey A, Smith JA, Barocas DA. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU International. 2011;107:206–211.
    1. Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy MN. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egyptian Nat Cancer Inst. 2007;19:158–162.
    1. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology. 2006;43:915–922.
    1. Haseeb AN, el-Shazly AM, Arafa MA, Morsy AT. A review on fascioliasis in Egypt. J Egypt Soc Parasitol. 2002;32:317–354.
    1. Kia EB, Rahimi H, Sharbatkhori M, Talebi A, Fasihi Harandi M, Mirhendi H. Genotype identification of human cystic echinococcosis in Isfahan, central Iran. Parasitol Res. 2010;107:757–760.
    1. Shahnazi M, Hejazi H, Salehi M, Andalib AR. Molecular characterization of human and animal Echinococcus granulosus isolates in Isfahan, Iran. Acta Trop. 2011;117:47–50.
    1. Fendri AH, Boulacel A, Brahami A. Hydatic cyst of the heart at the Constantine Erriadh teaching hospital (Algeria). A retrospective study from 2008 to 2009. Bull Soc Pathol Exot. 2010;103:305–308.
    1. Kassem HH. Hydatidosis – echinococcosis in Libya (review article) (2006). J Egypt Soc Parasitol. 3(2 Suppl):21–26.
    1. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents. 2010;36(Suppl 1):S62–S65.
    1. Uthman MA, Satir AA, Tabbara KS. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia. J Eur Acad Dermatol Venerol. 2005;19:431–436.
    1. AlSamarai AM, AlObaidi HS. Cutaneous leishmaniasis in Iraq. J Infect Developing Countries. 2009;3:123–129.
    1. Fathy FM, El-Kasah F, El-Ahwal AM. Emerging cutaneous leishmaniasis in Sirte-Libya: epidemiology, recognition and management. J Egypt Soc Parasitol. 2009;39:881–905.
    1. Mahdy MA, Al-Mekhlafi HM, Al-Mekhlafi AM, Lim YA, Bin Shuaib NO, et al. Molecular characterization of Leishmania species isolated from cutaneous leishmaniasis in Yemen. PLoS ONE. 2010;5:e12879. doi: .
    1. Mihoubi I, Picot S, Hafirassou N, de Monbrison F. Cutaneous leishmaniasis caused by Leishmania tropica in Algeria. Trans R Soc Trop Med Hyg. 2008;102:1157–1159.
    1. Talmi-Frank D, Jaffe CL, Nasereddin A, Warburg A, King R, et al. Leishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;82:814–818.
    1. Vinitsky O, Ore L, Habiballa H, Cohen-Dar M. Geographic and epidemiologic analysis of the cutaneous leishmaniasis outbreak in Northern Israel, 2000–2003. IMAJ. 2010;12:652–656.
    1. Harrat Z, Boubidi SC, Pratlong F, Benikhlef R, Selt B, et al. Description of a dermatropic leishmania close to L. killicki (Rioux, Lanotte & Pratlong 1986) in Algeria. Trans R Soc Trop Med Hyg. 2009;103:716–720.
    1. Al-Nahhas S, Shabaan M, Hammoud L, Al-Taweel A, Al-Jorf S. Visceral leishmaniasis in the Syrian Arab Republic: early detection using rK39. East Mediterr Health J. 2003;9:856–862.
    1. Bouhamdan SF, Bitar LK, Saghir HJ, Bayan A, Araj GF. Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut. J Med Liban. 2010;58:8–11.
    1. World Health Organization. Global health atlas. n.d.. Available: . Accessed 18 January 2012.
    1. Al-Khatib TK, Hamid AS, Al-Kuhlany AM, Al-Jabal MH, Raja'a YA. Rapid assessment of trachoma in 9 governates and Socotra Island in Yemen. East Mediterr Health J. 2006;12:566–572.
    1. Shahriari HA, Izadi S, Rouhani MR, Ghasemzadeh F, Maleki AR. Prevalence and causes of visual impairment and blindness in Sistan-va-Baluchestan Province, Iran: Zahedan Eye Study. Br J Ophthalmol. 2007;91:579–584.
    1. Hotez PJ. Enlarging the “audacious goal”: elimination of the world's high prevalence neglected tropical diseases. Vaccine. 2011 E-pub ahead of print 19 December 2011. doi:10.1016/j.vaccine.2011.06.024.
    1. World Health Organization. Global leprosy situation. Weekly Epidemiol Rec. 2010;85:337–348.
    1. Ahmed MO, Elmeshri SE, Abuzweda AR, Blauo M, Abouzeed YM, et al. Seroprevalence of brucellosis in animals and human populations in the western mountains region in Libya, December 2006–January 2008. Euro Surveill. 2010;15: pii:19625.
    1. Ooi EE, Gubler DJ. Dengue and dengue hemorrhagic fever (Ch. 75). In: Guerrant RL, Walker DH, editors. Tropical infectious diseases: principles, pathogens, and practice. 3rd edition. Saunders Elsevier; 2011.
    1. Ahmed MM. Clinical profile of dengue fever infection in King Abdul Aziz University Hospital Saudi Arabia. J Infect Dev. 2010;4:503–510.
    1. Chinikar S, Mojtaba Ghiasi S, Moradi M, Goya MM, Reza Shirzadi M, et al. Phylogenetic analsysis in a recent controlled outbreak of Crimean-Congo haemorrhagic fever in the south of Iran, December 2008. Euro Surveill. 2010;15: pii:19720.
    1. Al-Afaleq AI, Hussein MF. The status of Rift Valley fever in animals in Saudi Arabia: a mini review. Vector Borne Zoonotic Dis. 2011;11:1513–1520.
    1. Memish ZA, Charrel RN, Zaki AM, Fagbo SF. Alkhurma haemorrhagic fever–a viral haemorrhagic disease unique to the Arabian Peninsula. Int J Antimicrob Agents. 2010;36(Suppl 1):S53–S57.
    1. Hotez PJ. A handful of ‘antipoverty’ vaccines exist for neglected diseases, but the world's poorest billion need more. Health Aff (Millwood) 2011;30:1080–1087.
    1. McDowell MA, Rafati S, Ramalho-Ortigao M, Salah AB. Leishmaniasis: Middle East and North Africa research and development priorities. PLoS Negl Trop Dis. 2011;7:e1219. doi: .
    1. Jacobson RL. Leishmaniasis in an era of conflict in the Middle East. Vector Borne Zoonotic Dis. 2011;11:247–258.
    1. Davies FG. Risk of a rift valley fever epidemic at the haj in Mecca, Saudi Arabia. Rev Sci Tech. 2006;25:137–147.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere